Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges
出版年份 2022 全文链接
标题
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges
作者
关键词
-
出版物
Expert Opinion on Drug Delivery
Volume 19, Issue 10, Pages 1365-1380
出版商
Informa UK Limited
发表日期
2022-10-18
DOI
10.1080/17425247.2022.2135699
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States
- (2022) Anne M. Neilan et al. ANNALS OF INTERNAL MEDICINE
- Promise, perils and cautious optimism
- (2022) Morgan M. Philbin et al. Current Opinion in HIV and AIDS
- CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
- (2022) Tanuja Narayansamy Gengiah et al. BMJ Open
- Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches
- (2022) Alejandro J. Paredes et al. Materials Today Bio
- In vitro release testing method development for long-acting injectable suspensions
- (2022) Quanying Bao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery
- (2022) Tahir Khuroo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
- (2022) Sinead Delany-Moretlwe et al. LANCET
- Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
- (2022) Boris Julg et al. NATURE MEDICINE
- HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa
- (2022) Kristen M. Little et al. AIDS AND BEHAVIOR
- Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
- (2022) Suyash Deodhar et al. Nature Communications
- Direct visualization of the drug release process of non-conductive polymeric implants via molecular imaging
- (2022) Zhidan Liang et al. ANALYTICA CHIMICA ACTA
- A new combination bictegravir+tenofovir alafenamide nanoformulation with prolonged sustained-drug-release potency for HIV-1 PrEP: A concept evaluation study.
- (2021) Subhra Mandal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study
- (2021) Annalene Nel et al. Lancet HIV
- Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study
- (2021) Jared M Baeten et al. Lancet HIV
- Tenofovir Alafenamide (TAF) for HIV Prevention: Review of the Proceedings from the Gates Foundation Long Acting (LA) TAF Product Development Meeting
- (2021) Joseph W. Romano et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083
- (2021) Mark A Marzinke et al. JOURNAL OF INFECTIOUS DISEASES
- Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention
- (2021) Sai Archana Krovi et al. ADVANCED DRUG DELIVERY REVIEWS
- Women-specific routes of administration for drugs: A critical overview
- (2021) José das Neves et al. ADVANCED DRUG DELIVERY REVIEWS
- The role of sex as a biological variable in the efficacy and toxicity of therapeutic nanomedicine
- (2021) Shahriar Sharifi et al. ADVANCED DRUG DELIVERY REVIEWS
- Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs
- (2021) Panita Maturavongsadit et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ultra-long acting prodrug of dolutegravir and delivery system – Physicochemical, pharmacokinetic and formulation characterizations
- (2021) Tahir Khuroo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pills, injections, rings or implants? PrEP formulation preferences of PrEP-experienced African women for HIV prevention
- (2021) Kenneth Ngure et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
- (2021) Paul Thoueille et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
- (2021) Nagsen Gautam et al. Nature Communications
- Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
- (2021) Denise A. Cobb et al. Nature Communications
- Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy
- (2021) Isabella C. Young et al. Polymers
- Broadly Neutralizing Antibodies for HIV-1 Prevention
- (2021) Stephen R. Walsh et al. Frontiers in Immunology
- A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs
- (2021) Doris Zane et al. Microbiology Spectrum
- Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
- (2021) Ismaiel A. Tekko et al. ADVANCED FUNCTIONAL MATERIALS
- Microstructure, Quality, and Release Performance Characterization of Long-Acting Polymer Implant Formulations with X-Ray Microscopy and Quantitative AI Analytics
- (2021) Karthik Nagapudi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Simulate SubQ: The Methods and the Media
- (2021) David Li et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
- (2021) Randolph P. Matthews et al. NATURE MEDICINE
- Lenacapavir: a first-in-class HIV-1 capsid inhibitor
- (2021) Hadas Dvory-Sobol et al. Current Opinion in HIV and AIDS
- A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
- (2020) Meredith E. Davis-Gardner et al. mBio
- Predicting pharmacokinetics of a tenofovir alafenamide subcutaneous implant using PBPK modelling
- (2020) Rajith K. R. Rajoli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless rats
- (2020) Ying Jiang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A year-long extended release nanoformulated cabotegravir prodrug
- (2020) Tanmay A. Kulkarni et al. NATURE MATERIALS
- Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate
- (2020) Solange M Simpson et al. PHARMACEUTICAL RESEARCH
- Inter-species Differences in Tenofovir Alafenamide Fumarate Stability in Plasma
- (2020) Teresa L. Parsons et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
- (2020) Sharana Mahomed et al. JOURNAL OF INFECTIOUS DISEASES
- Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment
- (2020) Alexandra M Minnis et al. Journal of the International AIDS Society
- Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
- (2020) Raphael J Landovitz et al. Lancet HIV
- Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications
- (2020) Antons Sizovs et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Clinically established biodegradable long acting injectables: An industry perspective
- (2020) Christian Isalomboto Nkanga et al. ADVANCED DRUG DELIVERY REVIEWS
- Long-acting drugs and formulations for the treatment and prevention of HIV infection
- (2020) Charles Flexner et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fully synthetic injectable depots with high drug content and tunable pharmacokinetics for long-acting drug delivery
- (2020) Duy-Khiet Ho et al. JOURNAL OF CONTROLLED RELEASE
- Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis
- (2020) Manjula Gunawardana et al. Frontiers in Pharmacology
- Design and Testing of a Cabotegravir Implant for HIV Prevention
- (2020) Dipu Karunakaran et al. JOURNAL OF CONTROLLED RELEASE
- A new engineering process of biodegradable polymeric solid implants for ultra-long-acting drug delivery
- (2020) Panita Maturavongsadit et al. International Journal of Pharmaceutics: X
- 2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis
- (2019) Fernanda P. Pons-Faudoa et al. JOURNAL OF CONTROLLED RELEASE
- Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
- (2019) Ashana Puri et al. Pharmaceutics
- A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study
- (2019) Subhra Mandal et al. ANTIVIRAL RESEARCH
- Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3
- (2019) Martin Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
- (2019) Kamal Singh et al. Frontiers in Microbiology
- Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
- (2019) Leah M. Johnson et al. Pharmaceutics
- Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
- (2019) Yehuda Z. Cohen et al. PLoS One
- Synthesis of a long acting nanoformulated emtricitabine ProTide
- (2019) Dhruvkumar Soni et al. BIOMATERIALS
- Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK
- (2019) Rajith K.R. Rajoli et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
- (2019) S. Rahima Benhabbour et al. Nature Communications
- The potential of engineered antibodies for HIV-1 therapy and cure
- (2019) Marloes Grobben et al. Current Opinion in Virology
- Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
- (2019) Martin R Gaudinski et al. Lancet HIV
- A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques
- (2019) Jonathan T. Su et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A long acting nanoformulated lamivudine ProTide
- (2019) Nathan Smith et al. BIOMATERIALS
- Extended Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention
- (2018) Stephanie E. Barrett et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
- (2018) Tian Zhou et al. BIOMATERIALS
- HIV Preexposure Prophylaxis
- (2018) James Riddell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection
- (2018) Rajeev Gautam et al. NATURE MEDICINE
- The expanding role of prodrugs in contemporary drug design and development
- (2018) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Creation of a long-acting nanoformulated dolutegravir
- (2018) Brady Sillman et al. Nature Communications
- Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
- (2018) Ameya R. Kirtane et al. Nature Communications
- Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
- (2018) James J. Steinhardt et al. Nature Communications
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591
- (2018) Martin Markowitz et al. Current Opinion in HIV and AIDS
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
- (2018) Martin R. Gaudinski et al. PLOS MEDICINE
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2018) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis
- (2018) Corrine Ying Xuan Chua et al. JOURNAL OF CONTROLLED RELEASE
- The potential value of nanomedicine and novel oral dosage forms in the treatment of HIV
- (2018) James J Hobson et al. Nanomedicine
- Perspectives of South African youth in the development of an implant for HIV prevention
- (2018) Emily A Krogstad et al. Journal of the International AIDS Society
- Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques
- (2018) JoEllyn McMillan et al. AIDS
- Microneedles: A smart approach and increasing potential for transdermal drug delivery system
- (2018) Tejashree Waghule et al. BIOMEDICINE & PHARMACOTHERAPY
- Injectable long-acting human immunodeficiency virus antiretroviral prodrugs with improved pharmacokinetic profiles
- (2018) Sai Archana Krovi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension
- (2018) Maelíosa T.C. Mc Crudden et al. JOURNAL OF CONTROLLED RELEASE
- Ultra-long-acting removable drug delivery system for HIV treatment and prevention
- (2018) Martina Kovarova et al. Nature Communications
- Use of broadly neutralizing antibodies for HIV-1 prevention
- (2017) Amarendra Pegu et al. IMMUNOLOGICAL REVIEWS
- The ProTide Prodrug Technology: From the Concept to the Clinic
- (2017) Youcef Mehellou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them
- (2016) Alejandro Sosnik et al. ADVANCED DRUG DELIVERY REVIEWS
- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- The ProTides Boom
- (2016) Youcef Mehellou ChemMedChem
- Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate
- (2016) Vijaya Madhyanapu Golla et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development
- (2016) Eneko Larrañeta et al. MATERIALS SCIENCE & ENGINEERING R-REPORTS
- A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
- (2016) Rajeev Gautam et al. NATURE
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
- (2016) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis
- (2016) Erica Schlesinger et al. PHARMACEUTICAL RESEARCH
- Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
- (2016) Kshitij Wagh et al. PLoS Pathogens
- Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
- (2016) Annalene Nel et al. PLoS One
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque
- (2015) Cheryl A. Stoddart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Formulation and pharmacology of long-acting cabotegravir
- (2015) Christine Trezza et al. Current Opinion in HIV and AIDS
- Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy
- (2015) M.S. Palombo et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV
- (2014) Rajith K. R. Rajoli et al. CLINICAL PHARMACOKINETICS
- Design, Synthesis, Antiviral Activity, and Pre-Formulation Development of Poly-L-Arginine-Fatty Acyl Derivatives of Nucleoside Reverse Transcriptase Inhibitors
- (2014) Bhanu P. Pemmaraju et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Microneedles for intradermal and transdermal drug delivery
- (2013) Tuan-Mazlelaa Tuan-Mahmood et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Synthesis and Anti-HIV Activities of Glutamate and Peptide Conjugates of Nucleoside Reverse Transcriptase Inhibitors
- (2012) Hitesh K. Agarwal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Evaluation of Fatty Acyl Ester Derivatives of (−)-2′,3′-Dideoxy-3′-thiacytidine
- (2012) Hitesh K. Agarwal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Emtricitabine Prodrugs with Improved Anti-HIV Activity and Cellular Uptake
- (2012) Hitesh K. Agarwal et al. MOLECULAR PHARMACEUTICS
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men
- (2012) P. L. Anderson et al. Science Translational Medicine
- Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation
- (2010) G. van 't Klooster et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148
- (2010) Richard L. Mackman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis, antiviral and contraceptive activities of nucleoside–sodium cellulose sulfate acetate and succinate conjugates
- (2010) Hitesh K. Agarwal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
- (2010) Reuben Granich et al. Current Opinion in HIV and AIDS
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started